What They Did
Olive AI was a Columbus, Ohio-based healthcare AI startup that promised to automate hospital administrative processes -- insurance verification, prior authorizations, claims management, and revenue cycle operations. Founded by Sean Lane, the company raised $902 million in venture capital and reached a $4 billion valuation by mid-2021. It claimed its AI was deployed at 900+ hospitals across 40+ U.S. states.
How LLMs Killed Them
Olive AI is a cautionary tale of AI hype outpacing AI reality. The company marketed itself as an autonomous AI system, but investigations (including a 2023 Axios report) revealed it relied heavily on manual human intervention behind the scenes. The AI struggled with complex workflows and often required humans to fix errors. Healthcare clients reported delays, poor implementation, and inconsistent results. As generative AI raised expectations of what "AI" should deliver, the gap between Olive's promises and actual capabilities became untenable.
Timeline
- December 2020: Raised $225M at $1.5B valuation.
- July 2021: Raised $400M, reaching $4B valuation.
- 2021: Claimed deployment at 900+ hospitals in 40+ states.
- July 2022: Laid off 450 workers.
- September 2022: CFO, chief product officer, and payer market president all departed.
- February 2023: Another 200 layoffs.
- October 31, 2023: Shut down entirely. Sold clearinghouse business to Waystar and patient access business to Humata Health.
By the Numbers
- Raised $902 million in venture capital
- Peak valuation of $4 billion
- 650+ employees laid off across two rounds before shutdown
- CFO, CPO, and payer president all departed in September 2022
- Sold remaining assets for undisclosed amounts (likely pennies on the dollar)
- Called "one of the biggest AI healthcare failures in recent years"